Early Access — free while we kick the tires
EdgarHawk

Ward Shane

COO & CLO

Officer
1 filing analyzed · 1 company · Latest 2025-12-12

Companies

Company Buys Sells Direction
Cidara Therapeutics, Inc. CDTX 0 4 Net selling

Activity

December 2025
high
Sell
9,959 shares
$2,191,747
Significance 7/10

COO Shane Ward sells 9,959 shares of CDTX at $220.08 ($2.2M); stock near 52-week high after +106% in 30 days

Ward Shane, serving as COO & CLO, sold 9,959 shares at $220.08, reducing holdings by -28.5% from 35.0K to 25.0K shares. The transaction occurred when CDTX was -0.2% from its 52-week high of $220.98 and after a 30-day rally of +106.0% and 90-day surge of +236.2%. Despite the sharp stock appreciation, the company reported $0.00 quarterly revenue and net income of $-83.2M, with annual revenue declining -98.0% year-over-year and negative full-year profitability. The sale of a significant portion of executive holdings during peak valuation and exceptional near-term price appreciation, coupled with the company's deteriorating financial position, presents a notable divergence between equity-holder actions and the stock's recent momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access